#BeaconTherapeutics is preparing to file for approval of its #genetherapy for eye disorder #Xlinkedretinitispigmentosa (XLRP) after reporting positive results in a pivotal trial.
@pharmaphorum.bsky.socialExplore
@pharmaphorum.bsky.social
@pharmaphorum.bsky.social#BeaconTherapeutics is preparing to file for approval of its #genetherapy for eye disorder #Xlinkedretinitispigmentosa (XLRP) after reporting positive results in a pivotal trial.